FDA Lawsuits and Class Action Litigation in the Dietary Supplement Industry

Tuesday, September 26 | 9am-Noon

This workshop will examine FDA’s years-long court battle over the legality of DMAA, regulatory strategies to establish the safety of a new ingredient, an update on class action litigation, and tips to defend against lawsuits brought by regulators and the private plaintiffs’ bar.

Join us to unearth:

  • The status of FDA’s DMAA court case, and its implications, for the dietary supplement industry;
  • The pros and cons of a new dietary ingredient notification (NDIN) vs. self-affirmed GRAS (generally recognized as safe);
  • Trends in class action lawsuits; and
  • Strategies in mounting a defense in response to lawsuits filed by the government and private plaintiffs.


Michelle Jackson


Venable LLP


Matthew Orr

Consumer Health Industry Manager

Call & Jensen


Marc Ullman, Esq.

Of Counsel

Rivkin Radler LLP



Ivan Wasserman, Esq.


Amin Talati Upadhye LLP



Jack Wenik, Esq.


Epstein, Becker Green